Skip to main content

UBS Group AG

Position in EOLS — Evolus, Inc.

CIK 1610520 ZURICH, V8

Position in EOLS

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,094,340
-$2,766,762 QoQ
Shares Held
752,881
-14.6% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS Group AG holds $1,523,036,852 across 81 Drug Manufacturers - Specialty & Generic names. EOLS ranks #33 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EOLS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,094,340 752,881
2025-12-31 $5,861,102 881,369
2025-09-30 $6,324,911 1,030,116
2025-06-30 $9,915,338 1,076,584
2025-03-31 $11,472,517 953,659
2024-12-31 $12,071,190 1,093,405
2024-09-30 $10,453,875 645,301
2024-06-30 $7,083,650 652,871
2024-03-31 $7,996,548 571,182
2023-12-31 $7,015,980 666,285
2023-09-30 $7,077,841 774,381
2023-06-30 $6,982,435 960,445
2023-03-31 $163,861 19,369
2022-12-31 $109,915 14,636
2022-09-30 $16,905 2,100
2022-06-30 $53,360 4,600
2022-03-31 $158,998 14,171
2021-12-31 $57,489 8,831
2021-09-30 $56,273 7,385
2021-06-30 $185,144 14,636
2021-03-31 $201,006 15,474
2020-12-31 $65,718 19,559
2020-09-30 $205,809 52,637
2020-06-30 $347,414 65,550
2020-03-31 $220,883 53,225